Morphic Holding Inc (MORF)
33.46
+2.00
(+6.36%)
USD |
NASDAQ |
Jun 25, 16:00
33.46
0.00 (0.00%)
After-Hours: 20:00
Morphic Free Cash Flow: -128.61M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -128.61M |
| December 31, 2023 | -113.55M |
| September 30, 2023 | -110.07M |
| June 30, 2023 | -105.66M |
| March 31, 2023 | -105.15M |
| December 31, 2022 | -101.34M |
| September 30, 2022 | -97.20M |
| June 30, 2022 | -97.00M |
| March 31, 2022 | -92.24M |
| December 31, 2021 | -84.48M |
| September 30, 2021 | -77.93M |
| Date | Value |
|---|---|
| June 30, 2021 | -49.35M |
| March 31, 2021 | -47.74M |
| December 31, 2020 | -46.53M |
| September 30, 2020 | -46.83M |
| June 30, 2020 | -64.56M |
| March 31, 2020 | -62.68M |
| December 31, 2019 | -43.81M |
| September 30, 2019 | 63.37M |
| June 30, 2019 | 71.85M |
| March 31, 2019 | 80.96M |
| December 31, 2018 | 75.68M |
Free Cash Flow Range, Past 5 Years
-128.61M
Minimum
Mar 2024
71.85M
Maximum
Jun 2019
-66.98M
Average
-81.20M
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals Inc | 127.82M |
| Cytokinetics Inc | -421.55M |
| Amicus Therapeutics Inc | -88.03M |
| Insmed Inc | -588.55M |
| Madrigal Pharmaceuticals Inc | -391.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -46.39M |
| Cash from Investing (Quarterly) | 31.37M |
| Cash from Financing (Quarterly) | 0.911M |
| Free Cash Flow Per Share (Quarterly) | -0.9411 |
| Free Cash Flow Yield | -8.27% |